doi: 10.6515/ACS.202403_40(2).20240207A
JournalJOURNAL / NEWSLETTER
Volume 40 Number 2 March 2024
147 Heart Failure with Preserved Ejection Fraction: It’s Time to Act
148-171 2024 Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction
doi: 10.6515/ACS.202403_40(2).20240206A
172-181 LncRNA H19: A Novel Biomarker in Cardiovascular Disease
doi: 10.6515/ACS.202403_40(2).20230925A
182-190 The Impact of Intravenous Ferric Carboxymaltose on Reverse Electrical Remodeling Following Cardiac Resynchronization Therapy
doi: 10.6515/ACS.202403_40(2).20230828B
191-199 Incidence and Predictors of Acute Coronary Syndrome in Patients on Maintenance Hemodialysis: A Prospective Cohort Study
doi: 10.6515/ACS.202403_40(2).20231022A
200-207 The Relationship between Amount of Air Supplied to Radial Artery Compression Device Used after Transradial Procedure and Radial Artery Stenosis
doi: 10.6515/ACS.202403_40(2).20231212A
208-213 Comparison of Glidesheath Slender and Subcutaneous Nitrate Administration in Terms of Radial Artery Complications: A Retrospective Single-Center Experience
doi: 10.6515/ACS.202403_40(2).20231127A
214-224 Sirtuin 2 Exerts Regulatory Functions on Radiation-Induced Myocardial Fibrosis in Mice by Mediating H3K27 Acetylation of Galectin-3 Promoter
doi: 10.6515/ACS.202403_40(2).20231026B
225-234 Sirt1 Inhibits Atrial Fibrosis by Downregulating the Expression of the Transforming Growth Factor-β1/Smad Pathway
doi: 10.6515/ACS.202403_40(2).20230925B
235-241 Taiwan Society of Cardiology Heart Failure Registry 2020: Rationale and Design
doi: 10.6515/ACS.202403_40(2).20230822A
242-252 Acute Effect in Mechanical Efficiency by Pressure-Volume Loop Analysis after Transcatheter Aortic Valve Implantation
doi: 10.6515/ACS.202403_40(2).20231230A
253-257 Guidewire Fracture and Stent Shrinkage during Coronary Angiography
doi: 10.6515/ACS.202403_40(2).20231127B
258-259 Letter to the Editor; Comment on “Association between Premorbid Renin-Angiotensin-Aldosteron System Blockade and the Risk of Acute Kidney Injury in Critically Ill Patients”
doi: 10.6515/ACS.202403_40(2).20231206A
260-261 Risks and Benefits of Continuing Renin-Angiotensin-Aldosterone System Inhibitors in Critically-Ill Patients
doi: 10.6515/ACS.202403_40(2).20231206B
262-266 Instructions for Authors
TOP